GlassScriptPhysician profile
Alexandra Carrer
NPI 1902047343
$58,897.83
in general payments reported to CMS, 2019-2025
26 companies · $3,075 in 2025
The $3,075 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $145 · 2021: $6,338 · 2022: $17K · 2023: $3,016 · 2024: $31.90 · 2025: $3,075.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,820 · Consulting Fee: $1,676 · Food and Beverage: $626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,820.19 |
| Consulting Fee | $1,676.00 |
| Food and Beverage | $626.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $27,735.80 | 2019-2023 | |
| Globus Medical, INC. | $9,724.37 | 2019-2025 | Xlif, Excelsiusgps Robotic Navigation System |
| Nuvasive, INC. | $4,370.71 | 2019-2020 | |
| Choice Spine, LLC | $4,050.00 | 2022 | |
| Integrity Implants INC. | $1,932.50 | 2021 | |
| Stryker Corporation | $1,715.97 | 2021 | |
| Cerapedics INC. | $1,558.27 | 2019 | |
| Medicrea USA, Corp. | $1,368.98 | 2019 | |
| Centinel Spine, LLC | $1,275.14 | 2021 | |
| Si-Bone, INC. | $1,217.14 | 2019-2022 | |
| Gotham Surgical Solutions & Devices, INC. | $1,200.00 | 2021 | |
| Life Spine, INC. | $1,176.00 | 2023 | Dyna-Link Ti Barbs |
| Suvon Surgical LLC | $625.11 | 2025 | |
| Arthrex, INC. | $493.87 | 2025 | |
| Smith+Nephew, INC. | $115.17 | 2020-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $105.19 | 2019-2021 | |
| Boston Scientific Corporation | $38.97 | 2021 | |
| Providence Medical Technology, INC. | $31.90 | 2024 | |
| Zimvie INC. | $26.97 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.03 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $23.43 | 2020 | |
| Bioventus LLC | $21.54 | 2021 | |
| Terumo Bct, INC. | $21.30 | 2021 | |
| Royal Biologics, INC. | $15.64 | 2019 | |
| Orthogenrx INC. | $14.74 | 2021 | |
| Vertos Medical, INC. | $14.09 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Carrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.